NO20072393L - P13-kinase gamma hemmere for behandling av anemi - Google Patents

P13-kinase gamma hemmere for behandling av anemi

Info

Publication number
NO20072393L
NO20072393L NO20072393A NO20072393A NO20072393L NO 20072393 L NO20072393 L NO 20072393L NO 20072393 A NO20072393 A NO 20072393A NO 20072393 A NO20072393 A NO 20072393A NO 20072393 L NO20072393 L NO 20072393L
Authority
NO
Norway
Prior art keywords
anemia
treatment
kinase
inhibitors
gamma inhibitors
Prior art date
Application number
NO20072393A
Other languages
English (en)
Norwegian (no)
Inventor
Christian Rommel
Reinhard Wetzker
Angelika Mueller
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20072393L publication Critical patent/NO20072393L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20072393A 2004-10-12 2007-05-09 P13-kinase gamma hemmere for behandling av anemi NO20072393L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04104997 2004-10-12
PCT/EP2005/055156 WO2006040318A2 (fr) 2004-10-12 2005-10-11 Inhibiteurs de kinase gamma p13 pour le traitement de l'anemie

Publications (1)

Publication Number Publication Date
NO20072393L true NO20072393L (no) 2007-05-09

Family

ID=34929693

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072393A NO20072393L (no) 2004-10-12 2007-05-09 P13-kinase gamma hemmere for behandling av anemi

Country Status (14)

Country Link
US (1) US20090042773A1 (fr)
EP (1) EP1807075A2 (fr)
JP (1) JP2008515955A (fr)
KR (1) KR20070073857A (fr)
CN (1) CN101056633A (fr)
AU (1) AU2005293556A1 (fr)
BR (1) BRPI0517416A (fr)
CA (1) CA2580480A1 (fr)
EA (1) EA200700848A1 (fr)
IL (1) IL182110A0 (fr)
MX (1) MX2007004302A (fr)
NO (1) NO20072393L (fr)
WO (1) WO2006040318A2 (fr)
ZA (1) ZA200702435B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101052640B (zh) * 2004-09-03 2011-05-11 默克雪兰诺有限公司 吡啶亚甲基唑烷酮类及其作为磷酸肌醇抑制剂的用途
EP2046333A4 (fr) * 2006-07-24 2010-09-15 Glaxosmithkline Llc Dérivés de thiozolidinedione utilisés en tant qu'inhibiteurs de la p13-kinase
TW200911798A (en) 2007-08-02 2009-03-16 Amgen Inc PI3 kinase modulators and methods of use
AU2008343813B2 (en) 2007-12-19 2012-04-12 Amgen Inc. Inhibitors of PI3 kinase
US8268834B2 (en) 2008-03-19 2012-09-18 Novartis Ag Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
US20110172217A1 (en) * 2008-09-05 2011-07-14 Shionogi & Co., Ltd. Ring-fused morpholine derivative having pi3k-inhibiting activity
WO2010110380A1 (fr) * 2009-03-27 2010-09-30 興和株式会社 Composé de pipéridine condensé et agent pharmaceutique le contenant
EP2440556A1 (fr) * 2009-06-10 2012-04-18 Vertex Pharmaceuticals Incorporated Inhibiteurs de la phosphatidylinositol 3-kinase
US8633183B2 (en) * 2010-01-26 2014-01-21 Boehringer Ingelheim International Gmbh 5-alkynyl-pyrimidines
US8609672B2 (en) 2010-08-27 2013-12-17 University Of The Pacific Piperazinylpyrimidine analogues as protein kinase inhibitors
CN102584809B (zh) * 2011-01-14 2014-12-24 湘北威尔曼制药股份有限公司 胺基噻唑烷酮化合物及其制备方法与在制备抗肿瘤药物中的应用
EP2699569B1 (fr) 2011-04-22 2017-08-30 Jasco Pharmaceuticals, LLC Inhibiteurs d'aminopyrimidine kinase
KR101990605B1 (ko) 2011-11-04 2019-06-18 자스코 파머수티컬스, 엘엘씨 아미노피리미딘 키나아제 억제제
JO3398B1 (ar) 2011-12-22 2019-10-20 Novartis Ag مشتقات 2،3- ثانى هيدرو- بنزو[1,4] أوكسازين والمركبات المتعلقة بها كمثبطات كيناز فسفواينوسيتيد-3 (pi3k) لمعالجة على سبيل المثال التهاب المفاصل الروماتيدي
US9862711B2 (en) 2014-04-24 2018-01-09 Novartis Ag Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
BR112016024484A2 (pt) 2014-04-24 2017-08-15 Novartis Ag derivados de aminopiridina como inibidores de fosfatidilinositol 3-quinase
CA2945212A1 (fr) 2014-04-24 2015-10-29 Novartis Ag Derives amines de pyrazine utilisables en tant qu'inhibiteurs de la phosphatidylinositol 3-kinase
HRP20240793T1 (hr) 2018-04-18 2024-09-13 Constellation Pharmaceuticals, Inc. Modulatori enzima koji modificiraju metil, njihovi pripravci i upotreba
EP3797108B1 (fr) 2018-05-21 2022-07-20 Constellation Pharmaceuticals, Inc. Modulateurs de l'enzyme méthyl modifiant, compositions et leur utilisation.
LT4003532T (lt) 2019-07-24 2024-11-11 Constellation Pharmaceuticals, Inc. 7-chlor-2- (4-(3-metoksiazetidin-1-il)cikloheksil)-2,4-dimetil-n-((6-metil-4-(metiltio)-2-okso-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioksol-5-karboksamido kristalinės formos
JPWO2022163843A1 (fr) * 2021-02-01 2022-08-04

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW518219B (en) * 1996-04-26 2003-01-21 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
JP4782564B2 (ja) * 2002-07-10 2011-09-28 メルク セローノ ソシエテ アノニム アゾリジノン−ビニル縮合−ベンゼン誘導体
CN100579978C (zh) * 2002-11-22 2010-01-13 史密丝克莱恩比彻姆公司 化合物

Also Published As

Publication number Publication date
US20090042773A1 (en) 2009-02-12
CN101056633A (zh) 2007-10-17
WO2006040318A2 (fr) 2006-04-20
KR20070073857A (ko) 2007-07-10
CA2580480A1 (fr) 2006-04-20
ZA200702435B (en) 2008-06-25
EP1807075A2 (fr) 2007-07-18
JP2008515955A (ja) 2008-05-15
IL182110A0 (en) 2007-07-24
BRPI0517416A (pt) 2008-10-07
MX2007004302A (es) 2007-06-07
WO2006040318A3 (fr) 2006-08-10
EA200700848A1 (ru) 2007-10-26
AU2005293556A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
NO20072393L (no) P13-kinase gamma hemmere for behandling av anemi
NO20045486L (no) Nye forbindelser og deres anvendelse
NO20062335L (no) Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer
NO20044826L (no) Pyrrolidinderivater
NO20060001L (no) Nye P2X7-reseptorantagonister og deres anvendelse
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20050828L (no) lndol-3-svovelderivater
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20063470L (no) Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister
NO20054905L (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
NO20051826L (no) Heterosyklisk substituerte piperaziner for behandling av schizofreni
NO20075158L (no) Nye sykliske aminer
NO20071593L (no) Pyrimidinderivater
NO20054312L (no) HIV-replikasjonsinhiberende pyrimidiner og triaziner
NO20066055L (no) Pyridinderivater
NO20072689L (no) Tetrasykliske indolderivater som antivirale midler
NO20060324L (no) [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni
NO20051223L (no) Oksadiazoler som modulatorer av metabotropisk glutamat reseptor-5.
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
DK1807072T3 (da) Cycloalkyllactamderivater som inhibitorer af 11-beta-hydroxysteroid-dehydrogenase 1
NO20075059L (no) Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase
NO20062677L (no) Benzyleteraminforbindelser anvendbare som CCR-5-antagonister
NO20081001L (no) Derivater av karboksamid som antagonister for muskarinisk reseptor
NO20085087L (no) Nye heterocykliske forbindelser
NO20050088L (no) Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application